Crinetics Pharmaceuticals annual revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Crinetics Pharmaceuticals Revenue Growth & History (CRNX)
Crinetics Pharmaceuticals reported $7.7M in revenue for fiscal 2025, an increase of 640.71% from the previous fiscal year.
View full Crinetics Pharmaceuticals company overviewCrinetics Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.7M | $6.7M | +640.71% |
| 2024 | 2024-12-31 | $1.0M | −$3.0M | −74.11% |
| 2023 | 2023-12-31 | $4.0M | $4.0M | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | −$71,000 | −100.00% |
| 2020 | 2020-12-31 | $71,000 | −$1.1M | −94.05% |
| 2019 | 2019-12-31 | $1.2M | −$1.2M | −50.86% |
| 2018 | 2018-12-31 | $2.4M | $383,000 | +18.73% |
| 2017 | 2017-12-31 | $2.0M | $1.5M | +247.20% |
| 2016 | 2016-12-31 | $589,000 | — | — |
Crinetics Pharmaceuticals quarterly revenue
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $25.1M | $24.1M | +2336.28% |
| Q1 2026 | 2026-03-31 | $10.7M | $10.4M | +2873.41% |
| Q4 2025 | 2025-12-31 | $6.2M | $6.2M | — |
| Q3 2025 | 2025-09-30 | $143,000 | $143,000 | — |
| Q2 2025 | 2025-06-30 | $1.0M | $632,000 | +158.40% |
| Q1 2025 | 2025-03-31 | $361,000 | −$279,000 | −43.59% |
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | −$346,000 | −100.00% |
| Q2 2024 | 2024-06-30 | $399,000 | −$589,000 | −59.62% |
| Q1 2024 | 2024-03-31 | $640,000 | −$2.0M | −76.11% |
| Q4 2023 | 2023-12-31 | $0 | $4.0M | +100.00% |
| Q3 2023 | 2023-09-30 | $346,000 | −$112,000 | −24.45% |
| Q2 2023 | 2023-06-30 | $988,000 | $549,000 | +125.06% |
| Q1 2023 | 2023-03-31 | $2.7M | −$452,000 | −14.44% |
| Q4 2022 | 2022-12-31 | −$4.0M | — | — |
| Q3 2022 | 2022-09-30 | $458,000 | $458,000 | — |
| Q2 2022 | 2022-06-30 | $439,000 | — | — |
| Q1 2022 | 2022-03-31 | $3.1M | $3.1M | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q1 2021 | 2021-03-31 | $0 | −$71,000 | −100.00% |
| Q4 2020 | 2020-12-31 | $0 | −$321,000 | −100.00% |
| Q3 2020 | 2020-09-30 | $0 | −$505,000 | −100.00% |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $71,000 | −$296,000 | −80.65% |
| Q4 2019 | 2019-12-31 | $321,000 | −$460,000 | −58.90% |
| Q3 2019 | 2019-09-30 | $505,000 | −$43,000 | −7.85% |
| Q2 2019 | 2019-06-30 | $0 | −$657,000 | −100.00% |
| Q1 2019 | 2019-03-31 | $367,000 | −$75,000 | −16.97% |
| Q4 2018 | 2018-12-31 | $781,000 | $253,000 | +47.92% |
| Q3 2018 | 2018-09-30 | $548,000 | −$92,000 | −14.37% |
| Q2 2018 | 2018-06-30 | $657,000 | −$175,000 | −21.03% |
| Q1 2018 | 2018-03-31 | $442,000 | $397,000 | +882.22% |
| Q4 2017 | 2017-12-31 | $528,000 | — | — |
| Q3 2017 | 2017-09-30 | $640,000 | — | — |
| Q2 2017 | 2017-06-30 | $832,000 | — | — |
| Q1 2017 | 2017-03-31 | $45,000 | — | — |
Crinetics Pharmaceuticals revenue growth trends
Over the last five reported fiscal years, revenue grew from $71,000 to $7.7M, a compound annual growth rate of 155.27%. Crinetics Pharmaceuticals's latest reported quarter, Q2 2026, generated $25.1M in revenue, an increase of 2336.28% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Crinetics Pharmaceuticals source filings ↗